EPTACOG ALFA (ACTIVATED) — all Canadian products
11 DINs
8 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is EPTACOG ALFA (ACTIVATED), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02347121 | NIASTASE RT | NOVO NORDISK CANADA INC | Powder For Solution; Kit | Intravenous | EPTACOG ALFA (ACTIVATED) 2 MG | Approved | |
| 02417111 | NIASTASE RT | NOVO NORDISK CANADA INC | Powder For Solution; Kit | Intravenous | EPTACOG ALFA (ACTIVATED) 2 MG | Marketed | |
| 02417138 | NIASTASE RT | NOVO NORDISK CANADA INC | Kit; Powder For Solution | Intravenous | EPTACOG ALFA (ACTIVATED) 5 MG | Marketed | |
| 02417146 | NIASTASE RT | NOVO NORDISK CANADA INC | Kit; Powder For Solution | Intravenous | EPTACOG ALFA (ACTIVATED) 8 MG | Approved | |
| 02347113 | NIASTASE RT | NOVO NORDISK CANADA INC | Kit; Powder For Solution | Intravenous | EPTACOG ALFA (ACTIVATED) 1 MG | Approved | |
| 02347148 | NIASTASE RT | NOVO NORDISK CANADA INC | Kit; Powder For Solution | Intravenous | EPTACOG ALFA (ACTIVATED) 5 MG | Approved | |
| 02365669 | NIASTASE RT | NOVO NORDISK CANADA INC | Kit; Powder For Solution | Intravenous | EPTACOG ALFA (ACTIVATED) 8 MG | Approved | |
| 02417103 | NIASTASE RT | NOVO NORDISK CANADA INC | Powder For Solution; Kit | Intravenous | EPTACOG ALFA (ACTIVATED) 1 MG | Marketed | |
| 02239660 | NIASTASE | NOVO NORDISK CANADA INC | Powder For Solution | Intravenous | EPTACOG ALFA (ACTIVATED) 2.4 MG | Cancelled Post Market | |
| 02239661 | NIASTASE | NOVO NORDISK CANADA INC | Powder For Solution | Intravenous | EPTACOG ALFA (ACTIVATED) 4.8 MG | Cancelled Post Market | |
| 02239659 | NIASTASE | NOVO NORDISK CANADA INC | Powder For Solution | Intravenous | EPTACOG ALFA (ACTIVATED) 1.2 MG | Cancelled Post Market |
Browse other molecules: